XML 23 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Acquisition (Tables)
 6 Months Ended
Jun. 30, 2015
Business Combinations [Abstract]  
Business Acquisition, Pro Forma Information [Table Text Block]
The following supplemental table presents unaudited consolidated pro forma financial information as if the closing of the CSC Acquisition had occurred on January 1, 2014 (in thousands, except per share amounts):
 
 Three Months Ended June 30, 2014
 
Six Months Ended June 30, 2014
 
(As Reported)
 
(Proforma)
 
(As Reported)
 
(Proforma)
Revenues
$
4,489

 
$
4,982

 
$
8,545

 
$
9,255

Net loss
$
(12,770
)
 
$
(13,574
)
 
$
(26,600
)
 
$
(29,097
)
Net loss attributable to Caladrius Biosciences, Inc.
$
(12,605
)
 
$
(13,409
)
 
$
(26,287
)
 
$
(28,784
)
Net loss per share attributable to Caladrius Biosciences, Inc.
$
(0.40
)
 
$
(0.36
)
 
$
(0.88
)
 
$
(0.82
)
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
The fair value of assets acquired and liabilities assumed on May 8, 2014 is as follows (in thousands):

Cash and cash equivalents
$
51

Accounts receivable trade, net
45

Prepaids and other current assets
19

Property, plant and equipment, net
1,041

Other assets
201

Goodwill
14,092

In-Process R&D
34,290

Accounts payable
(333
)
Accrued liabilities
(2,014
)
Deferred tax liability
(13,901
)
Total
$
33,491